- Tytuł:
-
Cerveau Technologies Inc. and Prothena Sign Agreement to Provide Novel Tau Imaging Biomarker for Research and Development of Investigational Therapeutics for Neurodegenerative Diseases - Autorzy:
- Źródło:
-
Business Wire (English) . 01/10/2023.
Wiadomości